Vialwirebiotech, curated
September 30, 2026, 10:16 PM
September 12, 2026
- 3:09 AM · STAT News3:09 AMSTAT+: Breast cancer pill from AstraZeneca misses mark in pivotal trial — STAT News
September 11, 2026
- 7:30 PM · STAT News
- 6:17 PM · STAT News6:17 PMSTAT+: Pharma wins a battle over the cost of wastewater treatment in Europe — STAT News
- 12:00 PM · BioWorld12:00 PMSimtriyo, Lytenava headline FDA's July NME approvals — BioWorld
- 9:10 AM · Pharmaceutical Technology9:10 AMHIV charities lament NICE snub for Gilead’s twice-yearly lenacapavir — Pharmaceutical Technology
- 4:35 AM · Pharmaceutical Technology4:35 AMABEC to expand global manufacturing network with new Wilson facility — Pharmaceutical Technology
- 4:30 AM · Drug Discovery World4:30 AMNew Phase IIa data for RESP-X revealed at ERS Congress 2026 — Drug Discovery World
- 4:30 AM · STAT News
- 2:01 AM · PharmaVoice2:01 AMMerck builds around Keytruda; prediction markets raise new risks — PharmaVoice